World's 1st trial of drug developed from iPS cells to begin

World's 1st trial of drug developed from iPS cells to begin

Junya Toguchida, professor at Kyoto University, speaks at a press conference in Kyoto on Aug. 1, 2017, announcing that his team will begin the world's first clinical trial of a drug developed from induced pluripotent stem cells to treat fibrodysplasia ossificans progressiva, a rare bone disease. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000113489
  • Registered date
  • 2017/8/01 12:42:49
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2017 Kyodo News
  • Media size
  • 1545 × 1854 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 358.78(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos